G. Okan And P. VURAL, "Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine," Dermatologic Therapy , vol.35, no.3, 2022
Okan, G. And VURAL, P. 2022. Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine. Dermatologic Therapy , vol.35, no.3 .
Okan, G., & VURAL, P., (2022). Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine. Dermatologic Therapy , vol.35, no.3.
Okan, Gokhan, And Pervin VURAL. "Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine," Dermatologic Therapy , vol.35, no.3, 2022
Okan, Gokhan And VURAL, Pervin. "Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine." Dermatologic Therapy , vol.35, no.3, 2022
Okan, G. And VURAL, P. (2022) . "Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine." Dermatologic Therapy , vol.35, no.3.
@article{article, author={Gokhan Okan And author={Pervin VURAL}, title={Worsening of the vitiligo following the second dose of the BNT162B2 mRNA COVID-19 vaccine}, journal={Dermatologic Therapy}, year=2022}